Imperial Prostate

29/07/2026

Congratulations to our Clinical Research Fellow Nikhil Mayor who has been awarded a prestigious and highly competitive NIHR (National Institute for Health and Care Research) Doctoral Fellowship 🎉

Alongside Nikhil’s role as the Clinical Research Fellow for the prostate cancer screening trial, this award of over £500,000 provides an opportunity to further optimise screening pathways using MRI - including a prospective screening study called - more details coming soon!

24/07/2026

Last week, we shared the news about our new study which showed focal therapy could effectively treat prostate cancer. Here we share a patient's lived experience of receiving focal therapy 👇🏼

Dean, who is 53 years old from Birmingham, was diagnosed with prostate cancer in 2025. He explains: "I went to my GP surgery and they did a PSA test – and found my level was high, despite the fact I had no symptoms. I was referred to my local hospital for more tests.”

Further tests confirmed he had prostate cancer and he initially agreed to have radiotherapy with hormone therapy.

Dean then found out about focal therapy thanks to the charity Prost8UK and returned to his GP to request a referral to Charing Cross Hospital. The Imperial team decided he was a candidate for a focal therapy called cryotherapy – which freezes the tumour.

"My support group were so helpful to help me make the decision to have focal therapy,” says Dean. “In the end it was a no brainer – I opted for focal therapy as it is less invasive, and it was much faster.”

Dean had the operation on 5 March 2026. “I was in and out of hospital in one day – I travelled to the hospital in the morning, I had cryotherapy in the early afternoon,” explains Dean. “The whole procedure in theatre was only 1-1.5 hours and I went home later that day. The whole procedure was pretty quick.”

“I am doing very well, my recovery was pretty quick. I am so thankful. My care at Imperial was second to none. If I hadn’t had the information from Prost8 I would never have known focal therapy was an option."

Read more about our focal therapy story: https://www.imperial.nhs.uk/about-us/news/new-study-shows-focal-therapy-treats-prostate-cancer

Imperial College London National Institute for Health and Care Research Prost8UK Imperial Prostate

17/07/2026

17/07/2026

🚨 NEW PUBLICATION IN European Urology 🚨

We are pleased to share the largest and longest-term analysis of focal therapy by Imperial Prostate and UK colleagues, reporting 10-year outcomes after focal HIFU and cryotherapy in 3477 men at 14 UK hospitals, led by Alexander Light, Max Peters, Hashim U. Ahmed, and Taimur Shah.

48% of our cohort had unfavourable-intermediate- or high-risk disease at baseline. At 10 years we found:
🔹 99.9% had not died from their cancer
🔹 96.7% were free from metastasis

Based on our data, focal therapy could be considered as a first-line treatment for well-selected cases of non-metastatic prostate cancer alongside radical treatment. With the UK government's recent £2.8 million investment into focal therapy, we hope this will translate to more men being able to access this effective treatment across the country.

Read the full article for free: https://doi.org/10.1016/j.eururo.2026.05.007

We are also pleased to report some fantastic coverage across TV, radio, and print:

BBC News: Targeted prostate cancer treatment cuts risk of side effects, study suggests, by Fergus Walsh. Featuring Hashim U. Ahmed, Paul Sayer (Prost8 UK), Amy Rylance (Prostate Cancer UK), Preet Kaur Gill, and Rob Huxford. Read: https://www.bbc.co.uk/news/articles/cwyq3lnndvxo

BBC Breakfast: segment by Fergus Walsh, Naga Munchetty, and Charlie Stayt. Featuring Hashim Uddin Ahmed, Paul Sayer, Amy Rylance and Rob Huxford. Watch (from 1:20-1:24): https://www.bbc.co.uk/iplayer/episodes/b006v5tb/breakfast

BBC Radio 4: interview of Hashim Uddin Ahmed and Paul Sayer by Nick Robinson. Listen (from 1:22 to 1:27): https://www.bbc.co.uk/programmes/m002yw6y

BBC Radio London: interview of Taimur Shah by Riz Lateef. Listen (from 1:17-1:23): https://www.bbc.co.uk/sounds/play/live/bbc_london

Daily Mail: New prostate cancer therapy used by Jeremy Clarkson cuts side-effects risk. Featuring Hashim Uddin Ahmed and Amy Rylance. Read: https://www.dailymail.com/health/article-15983725/New-prostate-cancer-therapy-Jeremy-Clarkson-cuts-effects-risk.html

The Independent: Prostate cancer treatment used by Jeremy Clarkson as effective as radiotherapy, by Dave Clark. Featuring Alexander Light and Hashim Uddin Ahmed. Read: https://www.independent.co.uk/life-style/health-and-families/health-news/jeremy-clarkson-prostate-cancer-focal-therapy-b3016702.html

The Telegraph: Prostate cancer treatment used by Clarkson cuts risk of side effects. Featuring Alexander Light and Hashim Uddin Ahmed. Read: https://www.telegraph.co.uk/news/2026/07/17/clarkson-prostate-cancer-treatment-cuts-risk-side-effects/

Prostate Cancer UK: Men missing out on targeted treatments that have fewer side effects. Featuring Hashim Uddin Ahmed. Read: https://prostatecanceruk.org/about-us/news-and-views/2026/08/men-missing-out-on-focal-therapy

Imperial College Healthcare NHS Trust: New study shows focal therapy effectively treats prostate cancer, keeping patients cancer free ten years after treatment by Maria Tennant. Featuring Alexander Light, Hashim Uddin Ahmed, Taimur Shah, Paul Sayer, Amy Rylance, and Preet Kaur Gill. Read: https://www.imperial.nhs.uk/about-us/news/new-study-shows-focal-therapy-treats-prostate-cancer

Sky News: Prostate cancer treatment with fewer side effects 'as effective as radiotherapy and surgery. Featuring Alexander Light and Hashim Uddin Ahmed. Read: https://news.sky.com/story/prostate-cancer-treatment-with-fewer-side-effects-as-effective-as-radiotherapy-and-surgery-13564256

Imperial College London

25/06/2026

🎯 We are thrilled to announce that Focal One Robotic HIFU has arrived at Imperial College Healthcare NHS Trust!

We couldn’t do this without the hard work, skill and dedication of the Riverside Theatre Team. Huge thank you to Dr. James Wysock who joined us from New York to proctor out first cases and support the team as we begin this journey! 🚀

15/06/2026

We are staying local for this year in West London!

Imperial Prostate will be presenting 2️⃣ plenaries, 6️⃣ podiums & 5️⃣ posters with topics from uro-technology to screening to sustainability 🤖🌱

Looking forward to catching up with our collaborators, friends and colleagues! 💫

📅 Monday 15 June 2026

Impact of AI on Surgical Care
08:45-09:45 (Terence Millin)
📍 Digital Twins - Professor Rakesh Heer

Prostate Cancer
16:30-17:30 (Paddy O’Reilly)
📍 The added value of diffusion-weighted imaging and dynamic contrast- enhanced sequences in the diagnosis of localised radiorecurrent prostate cancer: an analysis from the FORECAST trial - Mr Alexander Light
📍 Variation in PSA testing rates across ethnic and socioeconomic groups in Northwest London - Mr Nikhil Mayor

Imperial College Healthcare NHS Trust | Imperial College London | Hashim Uddin Ahmed

12/06/2026

📣 The IP10-AVIDITY RCT is opening sites nationwide, currently recruiting from two main sites at Imperial College Healthcare NHS Trust and The Royal Marsden NHS Foundation Trust and identifying patients from Chelsea and Westminster Hospital NHS Foundation Trust and West Middlesex Hospital University Hospital

🌱 Current status: halfway through the embedded pilot phase

☎️ Contact us to join in widening patients' access to PSMA PET/CT

12/06/2026

The Prostate Imaging Standards for Screening Magnetic Resonance Imaging ( ): International Consensus Recommendations have just been published in JAMA Oncology 🗣️

⭐ 21 experts from 6 countries formed the recommendations
⭐ The PRISM recommendations provide wide-ranging guidance on the acquisition, reporting, and interpretation of in
⭐ Ongoing trials (including ) and screening pilots will be integral in validating the guidance
⭐ Read the Special Communication here:

This Special Communication provides consensus recommendations on the acquisition, interpretation, and reporting of prostate magnetic resonance imaging for cancer screening.

02/06/2026

We're expanding research, widening treatment options and tackling inequalities in prostate cancer care.

✅ All eligible Black men will be invited to join a landmark screening trial.

✅ A targeted NHS screening programme will also be rolled out.

More: https://www.gov.uk/government/news/major-expansion-of-research-and-treatment-for-prostate-cancer